Condition: ENDOMETRIAL CANCER · Sponsor: Anthony Costales, MD
This is a prospective, multi-center, randomized non-inferiority phase III study to evaluate if patients undergoing a minimally invasive surgery for early stage uterine cancer have cancer cells in the fluid that is obtained at the time of their surgery when a uterine manipulator is placed versus patients who do not have a uterine manipulator placed.
This description comes directly from the study's public registry record.
Anthony Costales, MD · 713-798-3495 · costales@bcm.edu
Roberto Vargas, MD · 216-444-3414 · vargasr@ccf.org
Always discuss trial participation with your own doctor first.
| Cleveland Clinic | Cleveland, Ohio, United States | Suspended |
| Baylor College of Medicine- McNair Campus | Houston, Texas, United States | Recruiting |
| Baylor College of Medicine | Houston, Texas, United States | Recruiting |
| Ben Taub General Hospital | Houston, Texas, United States | Recruiting |
| Harris Health System - Smith Clinic | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04586959